InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: nh post# 171461

Thursday, 04/17/2014 3:36:49 PM

Thursday, April 17, 2014 3:36:49 PM

Post# of 345746
The late Dr. Philip Thorpe / Dr. Alan Schroit (MD Anderson):

A novel “salting-out” procedure for the isolation of tumor-derived exosomes

Available online 13 April 2014

Zachary Brownlee | Kristi D. Lynn | Philip E. Thorpe | Alan J. Schroit

The last decade has seen an exponential growth in the number of exosome-related publications. Although many of these studies have used exosomes from biological fluids (blood, and ascites or pleural...

http://www.journals.elsevier.com/journal-of-immunological-methods/recent-articles/

http://www.sciencedirect.com/science/article/pii/S0022175914001203

..... ok, who is going to cough up some money for this? lol I think the only ones that can afford to do so are the ones selling and not buying Peregrine : ) .... lets go guys, cough it up so you can tell us again how wrong the buyers and longs are lol

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News